Close
ACHEMA MIDDLE EAST 2026

CHMP Endorses Beyfortusfrom Sanofi And Astrazenecas For RSV

Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to treat lower respiratory tract...

BioMarin, CSL- Haemophilia Gene Treatments Win ICER Backing

Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a...

Dupixent Charts A Win Before The FDA Prurigo Nodularis Order

Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals this year for the...

FDA Advisors Help Drug Amylyx For ALS, Altering Prior Stance

A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug, increasing the likelihood that...

With FDA Approval, Revance With Daxxify Will Rival Botox

Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people mistakenly call it by...

FDA Approves First Acid Sphingomyelinase Deficiency Cure

For intravenous infusion in paediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disorder that results in early death, the U.S....

Usual Pharma Compliance Issues Noted In FDA Warning Letters

According to a study of the reasons behind warning letters sent by the US Food and Drug Administration Center for Drug Evaluation and Research and Center for...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...